- 2010
- 2009
2010 AGENDA
Click here to download the Agenda
| Thursday, October 14th | |||||
| 7:00 - 7:30 | Continental Breakfast | ||||
| 7:30 - 7:35 | Welcome Remarks Emmett T. Cunningham Jr., MD, PhD, MPH , Partner - Clarus Ventures, LLC |
||||
| 7:35 - 8:00 | Funding Innovation – The Basics Speakers: Emmett T. Cunningham Jr., MD, PhD, MPH , Partner - Clarus Ventures, LLC Gil Kliman, General Partner- Life Sciences InterWest Partners Bill Link, Managing Director-Versant Ventures |
||||
| 8:00 - 10:00 | CEO Presentations from Private Device Companies | ||||
| 10:00 - 10:30 | Break – Networking and Refreshments |
||||
| 10:30 - 12:30 | CEO Presentations from Private Biotech/Pharma Companies | ||||
| 12:30 - 2:00 | Luncheon & Interview
The Road to Success
Guest Speaker: Bill Link Managing Director Versant Ventures Interviewed By: Jim Mazzo President – Abbott Medical Optics Inc. Senior Vice President – Abbott Laboratories | ||||
| 2:00 - 2:15 | A View of the Ophthalmic Sector |
||||
| 2:15 - 2:30 | Funding and Exit Trends in the Biotech and Medical Device Industries | ||||
| 2:30 - 3:00 | Device Module 1 | ||||
| 3:00 - 3:30 | Device Module 2 | ||||
| 3:30 - 4:00 | Break – Networking and Refreshments | ||||
| 4:00 - 4:30 | Focus Session: Highlighting Reimbursement | ||||
|
|||||
| 4:30 - 5:00 | Focus Session: Ophthalmic Drug Delivery |
||||
|
|||||
| 4:40 - 5:00 | Drug Delivery Panel | ||||
| 5:00 - 5:30 | Pharma Module 1 | ||||
| 5:30 - 6:00 | Pharma Module 2 | ||||
| 6:00 - 7:30 | Cocktail Reception | ||||
| 7:30 | Summit Adjourns | ||||
2009 AGENDA
Click here to download the Agenda
| Thursday, October 22nd | |
| 7:00 - 7:50 | Continental Breakfast |
| 7:50 - 8:00 | Welcome Emmett T. Cunningham Jr., MD, PhD, MPH Partner Clarus Ventures, LLC |
| 8:00 - 10:00 | CEO Presentations – Ophthalmic DEVICE Companies Facilitators:
Charles Warden Managing Director Versant Ventures Jim Mazzo Senior Vice President Abbott Medical Optics |
| 8:00 - 8:10 | AcuFocus, Inc. – Jim Socks, SVP Clinical & Regulatory Affairs |
| 8:10 - 8:20 | ReVision Optics, Inc. – J. Randy Alexander, President & CEO |
| 8:20 - 8:30 | PowerVision, Inc. – Barry Cheskin, President & CEO |
| 8:30 - 8:40 | NuLens Ltd. – Ori Gal, CEO |
| 8:40 - 8:50 | LenSx Lasers, Inc. – Ron Kurtz, MD, President & CEO |
| 8:50 - 9:00 | VisionCare Ophthalmic Technologies, Inc. – Allen Hill, President & CEO |
| 9:00 - 9:10 | WaveTec Vision – Tom Berryman, President & CEO |
| 9:10 - 9:20 | Ocular Therapeutix, Inc. – Amar Sawhney, PhD, President & CEO |
| 9:20 - 9:30 | OptiMedica Corporation – Mark Forchette, President & CEO |
| 9:30 - 9:40 | NeoVista, Inc. – John Hendrick, President & CEO |
| 9:40 - 9:50 | Oraya Therapeutics – Jim Taylor, President & CEO |
| 9:50 - 10:00 | Second Sight® Medical Products, Inc. – Rob Greenberg, MD, PhD & CEO |
| 10:10 - 10:30 | Networking & Refreshment Break |
| 10:30 - 12:40 | CEO Presentations – Biotech & Ophthalmic PHARMA Companies Facilitators:
Tony Adamis, MD Dept. of Ophthalmology & Visual Sciences University of Illinois Scott Whitcup , MD Executive VP, Research & Development and Chief Scientific Officer Allergan, Inc. |
| 10:30 - 10:40 | MacuSight – David Weber, PhD, President & CEO |
| 10:40 - 10:50 | Ophthotech Corporation – Samir Patel, MD, President & CEO |
| 10:50 - 11:00 | Taligen Therapeutics – Abbie Celniker, PhD, CEO |
| 11:00 - 11:10 | Eyetech Inc. – Michael Atieh, Executive Chairman |
| 11:10 - 11:20 | NeuroTech – Ted Danse, President & CEO |
| 11:20 - 11:30 | Aerie Pharmaceuticals, Inc. – Tom van Haarlem, MD, President & CEO |
| 11:30 - 11:40 | Panoptica, Inc. – Paul Chaney, President & CEO |
| 11:40 - 11:50 | SARCode Corporation – Tom Gadek, PhD, CEO |
| 11:50 - 12:00 | Lux Biosciences, Inc. – Ulrich Grau, PhD, President & CEO |
| 12:00 - 12:10 | Applied Genetic Technologies Corporation (AGTC) – Sue Washer, CEO |
| 12:10 - 12:20 | ESBATech – Dominik Escher, PhD, CEO |
| 12:20 - 12:30 | Sirion Therapeutics – Barry Butler, President & CEO |
| 12:30 - 12:40 | iCo Therapeutics – Andrew Rae, MBA, President & CEO |
| 12:40 - 2:00 | Luncheon Interview –
“The Road to Success” Andy Corley
President, B&L Surgical Former CEO, Eyeonics David Guyer
Partner, SV Life Sciences Former CEO, Eyetech Pharmaceuticals Interviewed by David Cassak Managing Director, Medical Devices FDC-Windhover |
| 2:00 - 2:15 | Ophthalmics – A view of the PUBLIC sector
Joe Gilliam
Executive Director JPMorgan Healthcare Investment Banking Jeff Hoffman Managing Director JP Morgan |
| 2:15 - 2:30 | Ophthalmics – A view of the PRIVATE sector Ellen Foster Licking Finance Bureau Chief Elsevier Business Intelligence |
| 2:30 - 3:00 | Panel Discussion ? Financing Ophthalmic Device Companies Panelists:
J. Randy Alexander President & CEO ReVision Optics Robert Anderson Senior Relationship Manager Silicon Valley Bank Marty Glick Angel Investor Ron Kurtz, MD President & CEO LenSx Lasers Bill Link, PhD Managing Director Versant Ventures Robert Maloney, MD, MA Chief Medical Officer Calhoun Vision Angela McFarlane President & CEO ForSight Labs Moderator: Gilbert Kliman – InterWest Partners |
| 3:00 - 3:30 | Panel Discussion – What are Ophthalmic Device Companies Looking For?
Panelists:
Bill Barton Sr. VP, International Markets Alcon Labs J. Andy Corley President Bausch & Lomb Surgical Jim Mazzo Senior Vice President Abbott Medical Optics Moderator: Bill Link – Versant Ventures |
| 3:30 - 3:50 | Networking & Refreshment Break |
| 3:50 - 4:10 | Anterior Segment Innovation – The Next Five Years of Innovation Richard Lindstrom, MD Founder & Attending Surgeon, Minnesota Eye Consultants Adjunct Professor Emeritus, University of Minnesota, Department of Ophthalmology Moderator: Mark Forchette, President & CEO – OptiMedica Corporation |
| 4:10 - 4:30 | Posterior Segment Innovation – The Next Five Years of Innovation Mark Blumenkranz, MD Professor & Chairman, Department of Ophthalmology Stanford University Moderator: Mark Forchette, President & CEO – OptiMedica Corporation |
| 4:30 - 4:45 | Regulatory issues – Ophthalmic Drugs Gary Novack, PhD Moderator: Emmett Cunningham, MD, PhD, MPH – Clarus Ventures |
| 4:45 - 5:00 | Regulatory issues – Ophthalmic Devices Judy Gordon, DVM Moderator: Emmett Cunningham, MD, PhD, MPH – Clarus Ventures |
| 5:00 - 5:30 | Panel discussion – Financing Ophthalmology Pharma Companies
Panelists:
Robin Bellas Morgenthaler Ventures Ted Danse NeuroTech Thomas Dyrberg Novo Ventures Samir Patel Ophthotech Moderator: Lutz Giebel – SV Life Sciences |
| 5:30 - 6:10 | Panel Discussion – What are Ophthalmic Pharma Companies Looking For?
Panelists:
Robert Kim, MD VP & Head of Clinical Ophthalmology GlaxoSmithKline David Lawrence Senior VP of Corporate Development Allergan, Inc. Schalon Newton, EDM VP, Strategic Marketing & Business Development Santen Flemming Ornskov, MD, MPH Corporate VP & Global President Bausch & Lomb Roman G. Rubio, MD Acting Director, Ophthalmology, Late Development Genentech Knut Sturmhoefel, PhD Head of Alliance Management in Business Franchise Novartis Moderator: Emmett Cunningham, MD, PhD, MPH – Clarus Ventures |
| 6:10 - 7:30 | Cocktail Reception |
| 7:30 | Summit Adjourns |